EPISODE · Feb 6, 2026 · 48 MIN
When a Condition Affecting One in Three Women Has No Approved Treatment: Building Solutions, with Peter Pacult, MBA
from Life Science Insights · host Third Eye Associates
A family tragedy exposes the massive gap between how well we fund cardiovascular disease versus conditions that affect one in three women; an entrepreneur decides to build the missing solution.In this episode, Avana Health CEO and Co-Founder Peter Pacult joins Dan Mazzucco to talk about transforming personal loss into clinical innovation — navigating the underfunding crisis in women's health, strategic pivoting from postpartum hemorrhage to acute heavy menstrual bleeding, creatively designing a Phase 1 trial to serve a dual purpose as a pathology study, and building partnerships by understanding what truly matters to each stakeholder in healthcare.This conversation is for medtech entrepreneurs who recognize that the biggest opportunities often hide in the areas that have been most neglected and who are ready to build solutions with both humility and strategic precision.Peter Pacult, MBA, is the CEO and Co-Founder of Avana Health, a clinical-stage women's health company focused on treating critical unmet needs in uterine health. With over 20 years of experience in finance and life sciences, he has led multi-million dollar drug development programs and built high-performance teams from the ground up. Peter serves on the steering committee for the Gates Foundation and NIH Innovation Equity Forum for women's health, and holds advisory roles with the Women's Health Catalyst and the Turing Institute's AI for Women's Health Working Group. He holds an MBA from the University of Michigan Ross School of Business with a focus on leadership and strategy, and a BA in History from Northwestern University. At Avana Health, Peter is developing a novel drug-device platform to treat abnormal uterine bleeding (affecting at least one in three women) and postpartum hemorrhage (the leading cause of maternal death globally), with the goal of making treatment accessible in low-resource settings and maternal care deserts.
What this episode covers
A family tragedy exposes the massive gap between how well we fund cardiovascular disease versus conditions that affect one in three women; an entrepreneur decides to build the missing solution.In this episode, Avana Health CEO and Co-Founder Peter Pacult joins Dan Mazzucco to talk about transforming personal loss into clinical innovation — navigating the underfunding crisis in women's health, strategic pivoting from postpartum hemorrhage to acute heavy menstrual bleeding, creatively designing a Phase 1 trial to serve a dual purpose as a pathology study, and building partnerships by understanding what truly matters to each stakeholder in healthcare.This conversation is for medtech entrepreneurs who recognize that the biggest opportunities often hide in the areas that have been most neglected and who are ready to build solutions with both humility and strategic precision.Peter Pacult, MBA, is the CEO and Co-Founder of Avana Health, a clinical-stage women's health company focused on treating critical unmet needs in uterine health. With over 20 years of experience in finance and life sciences, he has led multi-million dollar drug development programs and built high-performance teams from the ground up. Peter serves on the steering committee for the Gates Foundation and NIH Innovation Equity Forum for women's health, and holds advisory roles with the Women's Health Catalyst and the Turing Institute's AI for Women's Health Working Group. He holds an MBA from the University of Michigan Ross School of Business with a focus on leadership and strategy, and a BA in History from Northwestern University. At Avana Health, Peter is developing a novel drug-device platform to treat abnormal uterine bleeding (affecting at least one in three women) and postpartum hemorrhage (the leading cause of maternal death globally), with the goal of making treatment accessible in low-resource settings and maternal care deserts.
NOW PLAYING
When a Condition Affecting One in Three Women Has No Approved Treatment: Building Solutions, with Peter Pacult, MBA
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.